EFG Asset Management’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-110,961
| Closed | -$737K | – | 184 |
|
|
2025
Q1 | $737K | Sell |
110,961
-34,668
| -24% | -$230K | 0.12% | 176 |
|
|
2024
Q4 | $1.83M | Sell |
145,629
-98,791
| -40% | -$1.24M | 0.25% | 162 |
|
|
2024
Q3 | $4.52M | Buy |
244,420
+22,374
| +10% | +$414K | 0.76% | 24 |
|
|
2024
Q2 | $4.78M | Buy |
222,046
+71,044
| +47% | +$1.53M | 0.83% | 22 |
|
|
2024
Q1 | $4.06M | Sell |
151,002
-4,203
| -3% | -$113K | 0.7% | 39 |
|
|
2023
Q4 | $4.64M | Buy |
155,205
+4,137
| +3% | +$124K | 0.88% | 24 |
|
|
2023
Q3 | $3.09M | Buy |
151,068
+11,045
| +8% | +$226K | 0.73% | 47 |
|
|
2023
Q2 | $2.78M | Buy |
140,023
+1,968
| +1% | +$39.1K | 0.6% | 57 |
|
|
2023
Q1 | $2.37M | Buy |
138,055
+25,553
| +23% | +$438K | 0.52% | 63 |
|
|
2022
Q4 | $2.19M | Buy |
+112,502
| New | +$2.19M | 0.49% | 69 |
|